Elutia to Participate in Upcoming Investor Conferences
Elutia (Nasdaq: ELUT), a leader in drug-eluting biomatrix products, has announced its participation in two upcoming investor conferences in New York. Dr. Randy Mills, President and CEO, and Matt Ferguson, CFO, will represent the company at these events:
1. H.C. Wainwright 26th Annual Global Investment Conference:
- Presentation available on-demand from September 9, 2024, 7:00 a.m. ET
- One-on-one meetings on September 11, 2024
2. Lake Street Capital Markets 8th Annual Best Ideas Growth Conference:
- One-on-one meetings on September 12, 2024
Institutional investors can arrange meetings with Elutia's management through their H.C. Wainwright and Lake Street representatives.
Elutia (Nasdaq: ELUT), un leader nei prodotti biomatrix a rilascio di farmaco, ha annunciato la sua partecipazione a due prossimi conferenze per investitori a New York. Il Dr. Randy Mills, Presidente e CEO, e Matt Ferguson, CFO, rappresenteranno l'azienda a questi eventi:
1. 26a Conferenza Globale Annuale degli Investimenti H.C. Wainwright:
- Presentazione disponibile on-demand dal 9 settembre 2024, 7:00 a.m. ET
- Incontri uno a uno l'11 settembre 2024
2. 8a Conferenza Annuale delle Migliori Idee di Lake Street Capital Markets:
- Incontri uno a uno il 12 settembre 2024
Gli investitori istituzionali possono organizzare incontri con la direzione di Elutia attraverso i loro rappresentanti di H.C. Wainwright e Lake Street.
Elutia (Nasdaq: ELUT), líder en productos biomatrix que liberan fármaco, ha anunciado su participación en dos próximas conferencias para inversores en Nueva York. El Dr. Randy Mills, Presidente y CEO, y Matt Ferguson, CFO, representarán a la empresa en estos eventos:
1. 26ª Conferencia Anual Global de Inversión H.C. Wainwright:
- Presentación disponible a demanda a partir del 9 de septiembre de 2024, 7:00 a.m. ET
- Reuniones uno a uno el 11 de septiembre de 2024
2. 8ª Conferencia Anual de Mejores Ideas de Lake Street Capital Markets:
- Reuniones uno a uno el 12 de septiembre de 2024
Los inversores institucionales pueden organizar reuniones con la dirección de Elutia a través de sus representantes de H.C. Wainwright y Lake Street.
엘루티아 (Nasdaq: ELUT)은 약물 방출 생체 매트릭스 제품의 선두주자로서 뉴욕에서 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 랜디 밀스 박사(회장 겸 CEO)와 맷 퍼거슨(CFO)이 이 행사에 회사 대표로 참석합니다:
1. H.C. 웨인라이트 제26회 연례 글로벌 투자 콘퍼런스:
- 2024년 9월 9일 오전 7:00(동부 표준시)부터 주문형 발표 가능
- 2024년 9월 11일 일대일 미팅
2. 레이크 스트리트 캐피탈 마켓 제8회 연례 최고의 아이디어 성장 회의:
- 2024년 9월 12일 일대일 미팅
기관 투자자는 H.C. 웨인라이트 및 레이크 스트리트 대표를 통해 엘루티아 경영진과의 미팅을 조정할 수 있습니다.
Elutia (Nasdaq: ELUT), un leader dans les produits biomatrices à libération de médicaments, a annoncé sa participation à deux prochaines conférences investisseurs à New York. Dr. Randy Mills, Président et CEO, et Matt Ferguson, CFO, représenteront l'entreprise lors de ces événements :
1. 26e Conférence Annuelle Globale d'Investissement H.C. Wainwright:
- Présentation disponible à la demande à partir du 9 septembre 2024, 7h00 ET
- Réunions individuelles le 11 septembre 2024
2. 8e Conférence Annuelle des Meilleures Idées de Lake Street Capital Markets:
- Réunions individuelles le 12 septembre 2024
Les investisseurs institutionnels peuvent organiser des réunions avec la direction d'Elutia par l'intermédiaire de leurs représentants H.C. Wainwright et Lake Street.
Elutia (Nasdaq: ELUT), ein führendes Unternehmen im Bereich medikamentenfreisetzende Biomatrixprodukte, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen in New York angekündigt. Dr. Randy Mills, Präsident und CEO, sowie Matt Ferguson, CFO, werden das Unternehmen bei diesen Veranstaltungen vertreten:
1. 26. jährliche globale Investorenkonferenz von H.C. Wainwright:
- Präsentation ab dem 9. September 2024, 7:00 a.m. ET auf Abruf verfügbar
- Einzelgespräche am 11. September 2024
2. 8. jährliche Best Ideas Wachstumskonferenz von Lake Street Capital Markets:
- Einzelgespräche am 12. September 2024
Institutionelle Investoren können über ihre Vertreter von H.C. Wainwright und Lake Street Meetings mit der Geschäftsführung von Elutia vereinbaren.
- None.
- None.
SILVER SPRING, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York:
H.C. Wainwright 26th Annual Global Investment Conference
Format: Presentation and 1x1 Meetings
Presentation Date and Time (On-demand beginning): Monday, September 9, 2024, 7:00 a.m. ET
1x1 Meetings: Wednesday, September 11, 2024
Webcast: Click here
Lake Street Capital Markets 8th Annual Best Ideas Growth Conference
Format: 1x1 Meetings
Date: Thursday, September 12, 2024
Institutional investors interested in meeting with management during the conferences may reach out to their respective H.C. Wainwright and Lake Street representatives.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
FAQ
What investor conferences will Elutia (ELUT) participate in during September 2024?
When is Elutia's (ELUT) presentation at the H.C. Wainwright conference?
Who will represent Elutia (ELUT) at the upcoming investor conferences?
How can institutional investors meet with Elutia's (ELUT) management during these conferences?
